Spread of bloodborne viruses among Australian prison entrants

BMJ

Volumn 310, Issue 6975, 1995, Pages 285-

  Crofts, Nick ^a   Stewart, Tony ^a   Hearne, Peter ^b   Ping, Xin yi ^c   Breschkin, Alan M ^c   Locarnini, Stephen A ^c  

^a International Health Unit   (Australia)

^b Pentridge Hospital   (Australia)

^c FAIRFIELD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; ARTICLE; AUSTRALIA; BLOOD SAMPLING; DATA ANALYSIS; DEMOGRAPHY; DRUG ABUSE; FEMALE; HEALTH PROGRAM; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNIZATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PRISON; RISK FACTOR; SEROCONVERSION; VIRUS TRANSMISSION;

ADULT; FEMALE; HEPATITIS ANTIBODIES; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HIV ANTIBODIES; HIV INFECTIONS; HIV SEROPREVALENCE; HUMAN; INCIDENCE; MALE; PREVALENCE; PRISONERS; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; SUPPORT, NON-U.S. GOV'T; VICTORIA;

EID: 0028979513     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.310.6975.285     Document Type: Article

References (30)

1. Gaughwin MD Douglas RM Liew C Davies L Mylvaganam A Treffke H, et al. HIV prevalence and risk behaviours for HIV transmission in South Australian Prisons. AIDS 1991; 5: 845–51.
2. Indermauer D Upton K. Alcohol and drug use patterns of prisoners in Perth. Australian and New Zealand Journal of Criminology 1988; 3: 144–67.
3. Indermauer D. Substance abuse history of Fremantle prisoners: a survey conducted of prisoners. Perth: Western Australian Department of Corrective Services, 1990.
4. Dobinson I Ward P. Heroin and property crime: an Australian perspective. Journal of Drug Issues 1986; 16: 249–62.
5. Wolk J Wodak A Morlet A Guinan JJ Gold J. HIV-related risk-taking behaviour, knowledge and serostatus of IV drug users in Sydney. Med J Aust 1990; 152: 453.
6. Crofts N Hopper J Milner R Bowden DS Breschkin AM Locarnini SA. Hepatitis C virus infection among a cohort of Victorian injecting drug users. Med J Aust 1993; 159: 237–41.
7. Bell J Fernandes D Batey R. Heroin users seeking methadone treatment. Med J Aust 1990; 152: 361–4.
8. Hahn RA Onorato IM Jones A Dougherty J. Prevalence of HIV infection among intravenous drug users in the United States. JAMA 1989; 261: 2677–84.
9. Vlahov D Brewer TF Castro KG Narkunas JP Salive ME Ullrich J, et al. Prevalence of antibody to HIV-1 among entrants to US correctional facilities. JAMA 1991; 265: 1129–32.
10. Centers for Disease Control. National HIV seroprevalence surveys—summary of results: data from serosurveillance activities through 1989. Atlanta: United States Department of Health and Human Services, Public Health Service, Center for Disease Control, 1990.
11. Skidmore CA Robertson JR Robertson AA Elton RA. After the epidemic: follow up study of HIV seroprevalence and changing patterns of drug use. BMJ 1990; 300: 219–23.
12. Bird AG Gore SM Jolliffe DW Burns SM. Anonymous HIV surveillance in Saughton Prison, Edinburgh. AIDS 1992; 6: 725–33.
13. Donoghoe MC Stimson GV Dolan KA. Sexual behaviour of injecting drug users and associated risks of HIV infection for non-injecting sexual partners. AIDS Care 1989; 1: 51–8.
14. Kaldor J Elford J Wodak A Crofts N Kidd S. HIV prevalence among IDUs in Australia: a methodological review. Drug and Alcohol Review 1993; 12: 175–84.
15. Gaughwin MD Douglas RM Liew C Davies L Mylvaganam A Treffke H, et al. HIV prevalence and risk behaviours for HIV transmission in South Australia prisons. AIDS 1991; 5: 845–51.
16. Holsen DS Harthug S Myrmel H. Prevalence of antibodies to hepatitis C virus and association with intravenous drug abuse and tattooing in a national prison in Norway. Eur J Clin Microbiol Infect Dis 1993; 12: 673–6.
17. Watson PG Watts JR Nelson M. The incidence of Australia antigen and antibody in male prisoners of two Sydney penitentiaries. Med J Aust 1973; 2: 421–3.
18. Gaughwin MD. HIV/AIDS: risk behaviours—research findings and their implications for prevention. In: FortuinJed. Issues in HIV/AIDS in the Australian prison system. Canberra: Australian Institute of Criminology, 1992.
19. Okamoto H Munekata E Tsuda F Munekata E Akahane Y Sugair Y, et al. Enzyme-linked immunosorbent assay for antibodies against the capsid protein of hepatitis C virus with a synthetic oligopeptide. Japan J Exp Med 1990; 60: 223–33.
20. Breslow NE Day NE. Statistical methods in cancer research. Lyons: International Agency for Research on Cancer, 1980.
21. Greenland S Robins JM. Estimation of a common effect parameter from sparse follow-up data. Biometrics 1985; 41: 55–68.
22. Clayton D Hills M. Statistical models in epidemiology. Oxford: Oxford University Press, 1993: 81.
23. Australian National Council on AIDS. National HIV/AIDS strategy, 1993–4 to 1995–6. Canberra: Australian Government Printing Service, 1993.
24. Sugitani M Inchauspe G Shindo M Prince AM. Sensitivity of serological assays to identify blood donors with hepatitis C viraemia. Lancet 1992; 339: 1018–9.
25. Christie B. HIV outbreak investigated in Scottish jail. BMJ 1993; 307: 151–2.
26. Thompson SC Stevenson E Wilby R Crofts N. Hepatitis B infection in Victoria 1992: time to review the high risk vaccination strategy (letter). Med J Aust 1993; 159: 562–3.
27. Decker MD Vaughn WK Brodie JS Hutcheson RH Schaffner W. The incidence of hepatitis B in Tennessee prisoners. J Infect Dis 1985; 152: 214–7.
28. Bayas JM Bruguera M Martin V Vidal J Rodes J Salleras LY. Hepatitis B vaccination in prisons: the Catalonian experience. Vaccine 1993; 11: 1441–4.
29. Bird AG Gore SM. Inside methodology: HIV surveillance in prisons. AIDS 1991; 8: 1345–6.
30. Gore SM Bird AG. No escape: HIV transmission in jail. BMJ 1993; 307: 147–8.